Can a 6-Session CBT approach outperform traditional talk therapy for PTSD?

NCT ID NCT07710573

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests a short, focused cognitive-behavioral therapy (CBT) called Brief SEE FAR CBT against standard dynamic psychotherapy for adults with posttraumatic stress disorder (PTSD). Participants in the CBT group receive 6 weekly sessions targeting intrusive PTSD symptoms, then continue to a full 12-session protocol. The control group receives standard dynamic psychotherapy. Researchers track changes in PTSD, anxiety, depression, and other outcomes at several points over 3 months to see if the brief approach works as well or better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Brief SEE FAR CBT (cognitive-behavioral therapy) and dynamic psychotherapy
What this could lead to
If successful, this brief CBT approach could offer a faster, more focused treatment option for PTSD, reducing symptoms in fewer sessions.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The brief intervention may not be as effective as longer therapies for some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Center for Psychological Services Sha'ar Hanegev

    RECRUITING

    Sha'ar Hanegev, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.